NURS 6630 Lithium and Various Anticonvulsants as Mood Stabilizers for Bipolar Disorder
NURS 6630 Lithium and Various Anticonvulsants as Mood Stabilizers for Bipolar Disorder
Bipolar disorder is a unique disorder that causes shifts in
mood and energy, which results in depression and mania for clients. Proper
diagnosis of this disorder is often a challenge for two reasons: 1) clients
often present as depressive or manic, but may have both; and 2) many symptoms
of bipolar disorder are similar to other disorders. Misdiagnosis is common,
making it essential for you to have a deep understanding of the disorder’s
pathophysiology. For this Assignment, as you examine the client case study in
this week’s Learning Resources, consider how you might assess and treat clients
presenting with bipolar disorder.
Learning Objectives
Students will:
Assess client factors and history to develop personalized
plans of bipolar therapy for clients
Analyze factors that influence pharmacokinetic and
pharmacodynamic processes in clients requiring bipolar therapy
Evaluate efficacy of treatment plans
Analyze ethical and legal implications related to
prescribing bipolar therapy to clients across the lifespan
Learning Resources
Note: To access this week’s required library resources,
please click on the link to the Course Readings List, found in the Course
Materials section of your Syllabus.
Required Readings
Note: All Stahl
resources can be accessed through the Walden Library using this link. This link
will take you to a log-in page for the Walden Library. Once you log into the
library, the Stahl website will appear.
Stahl, S. M. (2013).
Stahl’s essential psychopharmacology: Neuroscientific basis and practical
applications (4th ed.). New York, NY: Cambridge University Press.
To access the following chapters, click on the Essential
Psychopharmacology, 4th ed tab on the Stahl Online website and select the
appropriate chapter. Be sure to read all sections on the left navigation bar
for each chapter.
Chapter 6, “Mood Disorders”
Chapter 8, “Mood Stabilizers”
Stahl, S. M., & Ball, S. (2009b). Stahl’s illustrated
mood stabilizers. New York, NY: Cambridge University Press.
To access the following chapters, click on the Illustrated
Guides tab and then the Mood Stabilizers tab.
Chapter 4, “Lithium and Various Anticonvulsants as Mood
Stabilizers for Bipolar Disorder”
Chapter 5, “Atypical Antipsychotics as Mood Stabilizers for
Bipolar Disorder”
Vitiello, B. (2013). How effective are the current
treatments for children diagnosed with manic/mixed bipolar disorder? CNS Drugs,
27(5), 331-333. doi:10.1007/s40263-013-0060-3
Note: Retrieved from Walden Library databases.
Chen, R., Wang, H., Shi, J., Shen, K., & Hu, P. (2015).
Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release
paroxetine in healthy Chinese subjects: comparison of traditional phenotype and
activity score systems. European Journal of Clinical Pharmacology, 71(7),
835-841. doi:10.1007/s00228-015-1855-6
Note: Retrieved from Walden Library databases.
Click here to ORDER an A++ paper from our Verified MASTERS and DOCTORATE WRITERS:NURS 6630 Lithium and Various Anticonvulsants as Mood Stabilizers for Bipolar Disorder
NURS 6630 Lithium and Various Anticonvulsants as Mood Stabilizers for Bipolar Disorder
Required Media
Laureate Education.
(2016f). Case study: An Asian American woman with bipolar disorder [Interactive
media file]. Baltimore, MD: Author
Note: This case study will serve as the foundation for this
week’s Assignment.
Optional Resources
Mostafavi, A., Solhi, M., Mohammadi, M., Hamedi, M.,
Keshavarzi, M., & Akhondzadeh, S. (2014). Melatonin decreases olanzapine
induced metabolic side-effects in adolescents with bipolar disorder: a
randomized double-blind placebo-controlled trial. Acta Medica Iranica, 52(10),
734-739.
Retrieved from http://acta.tums.ac.ir/index.php/acta
To prepare for this Assignment:
Review this week’s Learning Resources. Consider how to
assess and treat clients requiring bipolar therapy.
The Assignment
Examine Case Study: An Asian American Woman With Bipolar
Disorder. You will be asked to make three decisions concerning the medication
to prescribe to this client. Be sure to consider factors that might impact the
client’s pharmacokinetic and pharmacodynamic processes.
At each decision point stop to complete the following:
Decision #1
Which decision did you select?
Why did you select this decision? Support your response with
evidence and references to the Learning Resources.
What were you hoping to achieve by making this decision?
Support your response with evidence and references to the Learning Resources.
Explain any difference between what you expected to achieve
with Decision #1 and the results of the decision. Why were they different?
Decision #2
Why did you select this decision? Support your response with
evidence and references to the Learning Resources.
What were you hoping to achieve by making this decision?
Support your response with evidence and references to the Learning Resources.
Explain any difference between what you expected to achieve
with Decision #2 and the results of the decision. Why were they different?
Decision #3
Why did you select this decision? Support your response with
evidence and references to the Learning Resources.
What were you hoping to achieve by making this decision?
Support your response with evidence and references to the Learning Resources.
Explain any difference between what you expected to achieve
with Decision #3 and the results of the decision. Why were they different?
Also include how ethical considerations might impact your
treatment plan and communication with clients.
